Keytruda Extends Life for Those Fighting Hodgkin Lymphoma & It’s Now FDA-Approved as Treatment

Published Oct 19, 2020

Keytruda Extends Life for Those Fighting Hodgkin Lymphoma & It’s Now FDA-Approved as Treatment

People with relapsed or treatment-resistant classic Hodgkin Lymphoma now have FDA approval to use Keytruda. The immunotherapy treatment is proven to extend life.

NOW
PLAYING
Stage 4 Cancer Survivor Olivia Newton-John and Daughter Chloe Appear Together on the Tamron Hall Show
NOW
PLAYING
It's Cold, I Have Cancer, and the Lights Are Out in Texas
NOW
PLAYING
GMA Anchor Robin Roberts Leads Morning Prayer on Instagram, xx% of Americans with Cancer Use Faith to Cope
NOW
PLAYING
Remembering Farrah Fawcett on her 74th Birthday, Best Friend Alana Stewart: 'You Will Always Be Missed My Beautiful Friend'
NOW
PLAYING
New Acute Myeloid Leukemia (AML) Maintenance Treatment Extends Patients’ Lives
NOW
PLAYING
How a Clinical Trial Might Improve Your Outlook

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.